Study to Evaluate Efficacy and Safety of Belantamab-based Combinations for Relapsed Multiple Myeloma
NCT07637526
·
clinicaltrials.gov ↗
NOT_YET_RECRUITING
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Relapse Multiple Myeloma
Interventions
DRUG:
Belantamab mafodotin
DRUG:
Bortezomib
DRUG:
Dexamethasone
DRUG:
Pomalidomide
Sponsor
PETHEMA Foundation